Seth Klarman Jazz Pharmaceuticals PLC Transaction History
Baupost Group LLC
- $3.63 Billion
- Q2 2024
A detailed history of Seth Klarman (Baupost Group LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Baupost Group LLC holds 1,274,248 shares of JAZZ stock, worth $142 Million. This represents 3.74% of its overall portfolio holdings.
Number of Shares
1,274,248
Previous 833,696
52.84%
Holding current value
$142 Million
Previous $100 Million
35.47%
% of portfolio
3.74%
Previous 2.75%
Shares
4 transactions
Others Institutions Holding JAZZ
# of Institutions
499Shares Held
57.3MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$705 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$686 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$277 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$225 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$225 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.99B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...